Status:
UNKNOWN
Intensified, Inpatient Adaptation of Dialectical Behavior Therapy (DBT)
Lead Sponsor:
GGZ Rivierduinen
Collaborating Sponsors:
Erasmus Medical Center
Conditions:
Borderline Personality Disorder
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
An randomized clinical trial to investigate whether among adult borderline patients (18 - 40 year), intensified inpatient short term (12 weeks) inpatient Dialectical Behavior Therapy (DBT) is more eff...
Detailed Description
Objective: Goal is to evaluate the (cost-)effectiveness of a short term intensive DBT treatment program (12 weeks) versus outpatient DBT, in terms of reduction of suicidal and/or self-harming behavior...
Eligibility Criteria
Inclusion
- Patients admitted in the period of January 2013 until January 2014
- patients who fulfill the Diagnostic and Statistical Manual-IV Text Revision criteria for BPD,
- patients who have shown suicidal and/or self-harming behavior in the year preceding the admission/ start of DBT treatment, including the last month preceding baseline measurement,
- patients who show a severe level of borderline symptomatology ( \> 24 on the BPDSI),
- patients who are in sufficient command of the Dutch language
Exclusion
- :
- Intelligence Quotient \< 80,
- a chronic psychotic condition,
- bipolar disorder,
- hard drug abuse that requires inpatient detoxification,
- forced treatment framework,
- DBT in the year preceding intake.
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2015
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01904227
Start Date
February 1 2012
End Date
April 1 2015
Last Update
November 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LMC van den Bosch
Oegstgeest, Netherlands, 2342 AN